|
HS Code |
528061 |
| Chemical Name | (R)-(-)-1-Benzyl-3-Aminopyrrolidine |
| Cas Number | 134541-18-9 |
| Molecular Formula | C11H16N2 |
| Molecular Weight | 176.26 |
| Appearance | Colorless to pale yellow liquid |
| Optical Rotation | [α]D20 -52° (c=1, CHCl3) |
| Purity | Typically >98% |
| Boiling Point | 110-112°C at 0.6 mmHg |
| Storage Temperature | 2-8°C |
| Inchi Key | NYYVVDYGBZXQMA-VIFPVBQESA-N |
As an accredited (R)-(-)-1-Benzyl-3-Aminopyrrolidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 500 mg of (R)-(-)-1-Benzyl-3-Aminopyrrolidine is supplied in a sealed amber glass vial with a tamper-evident screw cap. |
| Shipping | (R)-(-)-1-Benzyl-3-Aminopyrrolidine is shipped in secure, sealed containers and appropriately labeled according to chemical safety standards. The packaging ensures protection from moisture and light, typically under ambient or refrigerated conditions. All shipments comply with local and international regulations for handling and transporting chemicals, ensuring prompt and safe delivery. |
| Storage | (R)-(-)-1-Benzyl-3-Aminopyrrolidine should be stored in a cool, dry, and well-ventilated area, away from incompatible substances such as strong oxidizers. Keep the container tightly closed and protected from light and moisture. Store at room temperature unless otherwise specified by the manufacturer, and ensure proper labeling to avoid accidental misuse. Always follow standard chemical storage protocols and guidelines. |
Applications of (R)-(-)-1-Benzyl-3-Aminopyrrolidine in Industrial ManufacturingAs a specialized manufacturer of (R)-(-)-1-Benzyl-3-Aminopyrrolidine, we supply this chiral intermediate for advanced synthesis in regulated sectors. Below, we detail specific, fully traceable industrial uses, process touchpoints, and compliance frameworks driving downstream transformation in high-value chemical fields. 1. Active Pharmaceutical Ingredient (API) Synthesis for CNS AgentsThis chiral aminopyrrolidine structure commonly functions as a building block in the synthesis of central nervous system (CNS) therapeutic intermediates. Our pharmaceutical clients employ this compound during enantioselective amine introduction stages. Strict process controls and documentation are maintained for integration into psychoactive agent synthesis under GMP protocols, ensuring traceability from chiral intermediate through to final API. Material input is optimized per batch-specific substrate conversion rates and target isomer purity, guided by clinical registration data and process validation requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Chiral Ligand Production for Asymmetric CatalysisOur clients in the fine chemical and catalyst manufacturing space adopt (R)-(-)-1-Benzyl-3-Aminopyrrolidine as a core precursor in their chiral ligand synthesis. This material enters their custom ligand design pipelines where precise stereochemical attributes directly influence catalyst activity and downstream selectivity, especially for hydrogenation and carbon-carbon bond formation. Ligand makers modify the aminopyrrolidine core via N-alkylation or coupling with other chiral auxiliaries, integrating it early in their catalyst precursor production lines under ISO-accredited procedures. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Specialty Fine Chemicals ManufacturingManufacturers in the fine organic synthesis sector select this aminopyrrolidine as a privileged intermediate for crafting advanced building blocks, particularly for nitrogen heterocycle functionalization. The chiral amine unit imparts asymmetric centers in advanced intermediates through sequential N-benzyl deprotection or further functional group transformations such as amidation, alkylation, or cyclization. These processes adhere to batch release standards defined by downstream specialty chemical users requiring lot-specific traceability and impurity control. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Precursor in Research-Scale Peptidomimetic SynthesisStructural diversity in peptidomimetic R&D relies heavily on chiral amine building blocks. (R)-(-)-1-Benzyl-3-Aminopyrrolidine functions as a specialized linear segment, allowing medicinal chemists to introduce conformational bias in bioactive peptidomimetics. In this application, our material supports route screening and lead optimization projects under GLP-compliant laboratory conditions. Researchers select input ratios after considering side chain sterics and peptide backbone orientation, targeting maximal bioactivity with precise control of configurational isomerism. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (R)-(-)-1-Benzyl-3-Aminopyrrolidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
After years in specialty amine synthesis, we’ve seen demand grow for high-purity chiral pyrrolidines like (R)-(-)-1-Benzyl-3-Aminopyrrolidine. This molecule stands out for chemists who want enantiomeric precision through each stage of drug or material development. We’ve approached its manufacture with an eye for the small details: protecting groups, solvent choice, reaction temperature, and effective separation techniques that keep final purity above 98%. Our batches consistently show strong optical rotation and minimal racemization, not because that’s what brochures promise, but because that’s what experienced QC teams see on the chromatogram and NMR every time.
(R)-(-)-1-Benzyl-3-Aminopyrrolidine offers a chiral nitrogen scaffold prized in asymmetric synthesis. Pharmaceuticals developers seek this compound for its role as a building block in APIs, especially when a specific R- or S-enantiomer delivers superior selectivity or pharmacological results. Year after year, we’ve worked with academic and pharmaceutical labs that demand rigorous batch consistency. Medicinal chemists often use this amine to build CNS-active molecules or tailor selective dopamine receptor ligands. Its structural features lower the probability of off-target interactions, a fact supported in recent med-chem journals and patent filings, and echoed in our own decades of customer feedback.
Key to its profile, the (R)-(-) enantiomer delivers reliable configuration even after multistep reactions. We see its benzyl protection group minimizing side reactions that can plague open-chain amines. Over repeated collaborations, industry researchers have mentioned how subtle shifts in chirality can flip biological activity, so using a proven, single-enantiomer supply is non-negotiable. Our process, developed through hundreds of kilo-lab runs, maintains that confidence for those working at preparative, pilot, or commercial scale.
Many companies chase after high yields. From a manufacturing standpoint, purity and repeatable crystallization matter just as much. With (R)-(-)-1-Benzyl-3-Aminopyrrolidine, our teams closely monitor reaction time and temperature, sometimes adjusting protocols batch by batch after reviewing real-time analytics. For every 100 kilograms produced, we see minimal deviation in optical rotation, HPLC profile, and melting point.
We avoid overreliance on automated systems. Our senior operators don’t just trust the readout—they check the output by TLC and GC, reviewing for trace levels of racemization or benzyl hydrogenolysis byproducts. These hands-on touches might seem slow in an age of digital chemistry, but the results show up in lower impurity levels and satisfied repeat orders. Partners in both the US and Europe have raised purity-bar for NMR, asking for detailed impurity tables at 0.1% thresholds; our team delivers those without hand-waving or creative accounting in COAs.
Our staff value transparent discussion about each molecule’s risks and handling quirks. Handling (R)-(-)-1-Benzyl-3-Aminopyrrolidine means extra attention to ventilation and solvent compatibility. The amine group, while stabilized by the benzyl cap, shows slight air- and moisture-sensitivity. In our facility, we train regularly for incidents involving spilled amines and have worked out transfer systems that minimize operator exposure. Rather than cutting corners, we document, rehearse, and refine SOPs all year long.
Feedback from technicians matters twice a year at our site review sessions. Suggestions like altered PPE types or revised storage guidelines aren’t theory—they shape tomorrow’s production cycle. Powerful amines like this one demand the right material compatibility for seals and containers. Our storage room, for instance, stays below 20°C, with humidity control and an independent alarm so we catch risk before product can degrade or polymerize. Countless test samples taken out under different conditions confirm that the material, properly sealed, resists degradation for months, holding yield and chirality.
Not all aminopyrrolidines behave alike. Colleagues from discovery chemistry teams highlight the difference between racemic and enantiopure material. Biological assays have flagged unanticipated side effects tied to the wrong stereochemistry—an avoidable risk if the starting amine comes from a validated process like ours. Our crystalline (R)-(-) material resists amorphization. We avoid solvents prone to residuals that could plague downstream columns or form artefacts in scale-up.
Generic sources sometimes list the same name, but we’ve reverse-analyzed market samples showing mixed stereochemistry, unreacted benzyl chloride, or solvent residues above safe thresholds. Our plant uses USP-grade solvents and a multi-stage purification sequence. Chiral HPLC with independently-certified standards tells the real story for incoming QC. By staying in control of every synthetic stage—from starting amines all the way through final packing—we cut the risk of regulatory headaches or batch recall.
Scaling up pyrrolidine derivatives never follows a straight line. What works in a ten-gram round-bottom sometimes stalls out at kilogram scale, and that’s where in-house expertise counts. Early batches produced at lab scale showed local overheating; we addressed that by redesigning the jacket setup and adding in-line analytics. Our teams adjusted crystallization profiles to keep yield above 87% without sacrificing enantiopurity. Over the years, we’ve invested in revalidating our process after equipment upgrades and after raw material vendor changes. That diligence prevents batch-to-batch drift, especially under tight regulatory timelines from pharmaceutical partners.
Another lesson has come from logistics. (R)-(-)-1-Benzyl-3-Aminopyrrolidine cannot travel as blithely as basic solvents or bulk commodity amines. Our packing team lines every drum with inert materials and uses tamper-evident seals. Sea and air shipments receive thermal insulation and climate logging during transit. Over dozens of international shipments, not a single customer has reported container breach or unexplained product drop in quality, a fact that reflects not just protocol but personal pride in the team’s vigilance.
Working with companies under the world’s strictest regulatory regimes means our audit trail extends from raw material intake to final certificate of analysis. GMP-grade clients have audited our plant, sending their own QC experts for line walks and procedure reviews. We keep batch records that go beyond government requirements—every deviation logged, every fix documented. Our HSE department follows up after every campaign to make sure lessons learned from one batch carry through to the next run.
Beyond meeting customer specs, the chemistry community has a larger responsibility: ensuring molecules entering trial or commercial use reflect not just chemical, but ethical quality. Some regulatory filings trace impurities to the enantiopure building blocks. Because our staff have weathered recalls elsewhere in their careers, they keep a close eye on documentation, not just chemistry, to prevent regulatory delays or post-launch surprises. Transparency builds real trust in the supply chain.
We’ve participated in projects where the fate of a novel therapy or specialty material rests on the reliability of every single batch of (R)-(-)-1-Benzyl-3-Aminopyrrolidine. Our teams engage with customers through direct dialogue—discussing real-world process concerns rarely captured in product listings. Clients seek advice on reaction parameters, protection/deprotection sequences, or potential scale-up pitfalls. Sometimes those questions relate to stability under light, dilution strategies, or even alternative salt forms. With experience comes an understanding of what engineers and chemists want to know before they commit to a scale or regulatory pathway.
Our product development cycle incorporates repeated customer feedback. Researchers on tight timelines contact us about shipment tracking or ask for batch reanalysis; we deliver updated documents and manage expedited analytical requests without pushing them to an answering machine. From time to time, end-users flag minor shifts in physical form. We maintain transparency, recalling retained samples to run extra tests or even producing new batches at short notice if warranted. That responsiveness, developed over years of manufacturing, means most projects stay on track from lead optimization through clinical or pilot production.
Peer collaboration has improved our solvents and helped us reduce overall waste by 20% compared to early campaigns. With major pharma firms pushing for “greener” amine routes, we’ve developed less hazardous alternatives to classical hydrogenolysis, connecting in real time with environmental compliance teams. As a result, effluent loads and environmental emissions measure well below regulated thresholds. Operators and chemists alike make these suggestions stick because they see the long-term value of a cleaner, safer process in every batch.
We’ve seen colleagues wrestle with bottlenecks that a rigorous manufacturing approach prevents—delayed batch release, unpredictable melting points, or incompatibilities in downstream coupling stages. By charting in-process analytics and running parallel stability samples, we’ve flagged minor shifts in impurity profiles, fixing issues before they travel down the supply chain. Extended stability testing gives our partners room to plan ahead, protecting against raw material volatility or short-notice order spikes.
We’ve never relied on batch blending to compensate for off-target specs; every barrel must meet its own high standard. Our technical support doesn’t end after shipment. Teams regularly field questions about optimal coupling agents, solubility in scale-up, and compatibility with novel protecting groups. Our knowledge accumulates with every round of feedback and every learning moment in the plant.
Every time we deliver (R)-(-)-1-Benzyl-3-Aminopyrrolidine, we know the impact stretches from custom peptide routes to exploratory CNS agents. Our chemists, engineers, and operators bring hands-on experience with chiral amine chemistry from R&D through to full-scale production. We invest in continuing education for our team, sending them to conferences and review seminars, so the latest thinking on asymmetric synthesis comes back to the production floor and gets implemented without delay.
Quality comes from a culture of mutual respect and verification—not from automated emails or templated documentation. When quality deviations arise, cross-functional teams gather for root-cause analysis. That transparency builds resilience into the process and, ultimately, into our customer relationships.
(R)-(-)-1-Benzyl-3-Aminopyrrolidine remains a challenging yet rewarding product. Through a decades-long manufacturing journey, we’ve learned from every scale-up, every analytical request, and every shipment review. Partners rely on our material because it delivers on the promise of chiral integrity, batch-to-batch purity, and informed customer engagement. Our commitment reflects both pride in chemical manufacturing and a responsibility to the broader research community.
We value direct communication, ongoing innovation, and sharing experience-driven insights with partners who depend on premium chiral building blocks. That shared dedication helps move the next generation of pharmaceuticals, agrochemicals, and advanced materials from bench to product launch. Every day, we work with (R)-(-)-1-Benzyl-3-Aminopyrrolidine so the world’s laboratories and production lines receive not just a chemical, but a standard that sets the pace for thoughtful manufacturing.